TANG CAPITAL PARTNERS LP 13D and 13G filings for Quince Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | Quince Therapeutics, Inc. QNCX |
TANG CAPITAL PARTNERS LP | 3,220,000 7.500% |
-400,000 (-11.05%) |
Filing |
| 2023-03-31 4:00 pm Purchase |
2023-03-21 | 13G | Quince Therapeutics, Inc. QNCX |
TANG CAPITAL PARTNERS LP | 3,620,000 9.980% |
3,620,000 (New Position) |
Filing |